HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.

AuthorsG Morstyn, W Sheridan, G Lieschke, J Cebon, J Layton, R Fox
JournalProgress in clinical and biological research (Prog Clin Biol Res) Vol. 354B Pg. 29-36 ( 1990) ISSN: 0361-7742 [Print] United States
PMID1700441 (Publication Type: Journal Article, Review)
Chemical References
  • Antineoplastic Agents
  • Granulocyte Colony-Stimulating Factor
  • Etoposide
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Carboplatin
Topics
  • Antineoplastic Agents (adverse effects)
  • Carboplatin (adverse effects)
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Drug Evaluation
  • Etoposide (adverse effects)
  • Granulocyte Colony-Stimulating Factor (adverse effects, pharmacokinetics, therapeutic use)
  • Granulocyte-Macrophage Colony-Stimulating Factor (adverse effects, pharmacokinetics, therapeutic use)
  • Humans
  • Injections, Subcutaneous
  • Neutropenia (chemically induced, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: